Comparison of Effects of Rosuvastatin and Atorvastatin on Plaque Regression in Korean Patients With Untreated Intermediate Coronary Stenosis

作者
Young Joon Hong,Myung Ho Jeong,Daisuke Hachinohe,Khurshid Ahmed,Yun Ha Choi,Sook Hee Cho,Seung Hwan Hwang,Jum Suk Ko,Min Goo Lee,Keun Ho Park,Doo Sun Sim,Nam Sik Yoon,Hyun Ju Yoon,Kye Hun Kim,Hyung Wook Park,Ju Han Kim,Youngkeun Ahn,Jeong Gwan Cho,Jong Chun Park,Jung Chaee Kang
出处
期刊:Circulation journal [Japanese Circulation Society]
卷期号:75 (2): 398-406 被引量:41
标识
DOI:10.1253/circj.cj-10-0658
摘要

BACKGROUND: Serial intravascular ultrasound (IVUS) was used to compare the effects of moderate doses of rosuvastatin and atorvastatin on plaque regression in patients with intermediate coronary stenosis. METHODS AND RESULTS: This was a prospective, randomized, and comparative study for lipid-lowering therapy with rosuvastatin 20mg (n=65) and atorvastatin 40mg (n=63) using serial IVUS (baseline and 11-month follow-up). Efficacy parameters included changes in total atheroma volume (TAV) and percent atheroma volume (PAV) from baseline to follow-up. Changes of TAV (-4.4±7.3 vs. -3.6±6.8mm(3), P=0.5) and PAV (-0.73±2.05 vs. -0.19±2.00%, P=0.14) from baseline to follow-up were not significantly different between the 2 groups. Plaque was increased in 15% in the rosuvastatin group and in 30% in the atorvastatin group at follow-up (P=0.064). The plaque increase group had higher baseline high-sensitivity C-reactive protein (hs-CRP; 1.28±2.70mg/dl vs. 0.54±1.16mg/dl, P=0.034) and higher follow-up low-density lipoprotein cholesterol (LDL-C) (78±24mg/dl vs. 63±21mg/dl, P=0.002) compared with the plaque non-increase group. Follow-up LDL-C (odds ratio [OR]=1.038, 95% confidence interval [CI]=1.003-1.060, P=0.036) and baseline hs-CRP (OR=1.025, 95%CI=1.001-1.059, P=0.046), not the type of statin, were the independent predictors of plaque increase at follow-up. CONCLUSIONS: Moderate doses of rosuvastatin and atorvastatin could contribute to effective plaque regression. Follow-up LDL-C and baseline hs-CRP are associated with plaque progression in patients with intermediate coronary stenosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LUXURY完成签到,获得积分10
刚刚
Akim的应助被现代的随阴采纳,获得10
刚刚
lblb完成签到,获得积分10
1秒前
8R60d8的应助被风吹麦浪采纳,获得10
1秒前
李健的应助被zzq采纳,获得10
1秒前
sl完成签到,获得积分10
1秒前
深情安青的应助被fangxiang采纳,获得10
2秒前
简单晓博发布了新的文献求助10
3秒前
隐形曼青的应助被科研通管家采纳,获得10
3秒前
4秒前
元元酱完成签到,获得积分10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
orixero的应助被科研通管家采纳,获得10
4秒前
lb完成签到,获得积分10
4秒前
李爱国的应助被科研通管家采纳,获得10
4秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
4秒前
4秒前
CodeCraft的应助被胡佳琦采纳,获得10
4秒前
SciGPT的应助被科研通管家采纳,获得10
4秒前
bkagyin的应助被科研通管家采纳,获得10
4秒前
CipherSage的应助被科研通管家采纳,获得10
5秒前
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
LUXURY发布了新的文献求助10
5秒前
Hello的应助被科研通管家采纳,获得10
5秒前
打打的应助被科研通管家采纳,获得10
5秒前
NexusExplorer的应助被科研通管家采纳,获得10
5秒前
syvshc的应助被科研通管家采纳,获得10
5秒前
英姑的应助被科研通管家采纳,获得10
6秒前
hhnjhhb完成签到,获得积分10
6秒前
大个的应助被科研通管家采纳,获得10
6秒前
6秒前
8秒前
goodspeed完成签到,获得积分10
8秒前
8秒前
8秒前
9秒前
思源的应助被眼睛大的之卉采纳,获得20
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239